In contrast, in 108 patients with BC (UK cohort) who received NAC (capecitabine plus docetaxel preceded by adriamycin and cyclophosphamide), high levels of CD163+ TAMs significantly correlated with a pCR both in tumor and metastatic axillary LNs (98). Here, CD163 is linked to breast cancer.